Skip to content

    Anondita Medicare Ltd

    Noida-based manufacturer of male & female latex/non-latex condoms and sexual-wellness products under the COBRA brand.

    Fast Moving Consumer Goods
    Fast Moving Consumer Goods
    View ANONDITA earnings calls

    Overview

    Price

    Market Cap

    ₹2.0k Cr

    Sector

    Fast Moving Consumer Goods

    Fast Moving Consumer Goods

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY25FY26FY26
    LiabilitiesEquity Capital131818
    Reserves2591111
    Borrowings274734
    Other Liabilities132122
    Total Liabilities78176185
    AssetsFixed Assets141384
    CWIP6150
    Investments330
    Other Assets55145101
    Total Assets78176185

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY25FY26
    ActivitiesCash from Operating-1011
    Cash from Investing-23-63
    Cash from Financing3361
    SummaryCapital Expenditure
    Free Cash Flow-30-52
    FCF Margin

    Valuation

    Assumptions

    Current — ANONDITA
    Price
    ₹1,193
    EPS (TTM)
    ₹29.54
    PE (TTM)
    40.4
    Profit growth

    The Earnings Per Share over the last 12 months.

    %

    Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).

    Pre-filled with the lower of median (22.3×) and current (40.4×) PE — the conservative anchor.

    %

    The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.

    Valuation

    Current price
    ₹1,193
    vs
    Fair value · 15% return
    ₹450
    62%Overvalued

    At 10% growth and a 22× exit, ₹1193 only delivers your return if you pay ₹450. The price is currently baking in 31% growth.

    EPS grows 10%/yr for 5 years, then fades to 6% over 2, exits at 22×.

    YearGrowthEPS (₹)
    FY2710.0%32.49
    FY2810.0%35.74
    FY2910.0%39.32
    FY3010.0%43.25
    FY3110.0%47.57
    FY328.0% ·fade51.38
    FY336.0% ·fade54.46

    Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.

    Learn to analyse Anondita Medicare Ltd

    Guides on how to read this kind of business and the numbers that matter.